Bionomics ( (BNOX) ) has issued an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Neuphoria Therapeutics Inc. has completed its redomiciliation, transferring governance from Bionomics’ organizational documents to Neuphoria’s new Certificate of Incorporation and bylaws. This strategic move positions Neuphoria as the successor issuer to Bionomics, with its shares now registered under the Exchange Act, which may influence its governance structure and shareholder rights.
More about Bionomics
YTD Price Performance: -83.65%
Average Trading Volume: 9,738,552
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.72M
Find detailed analytics on BNOX stock on TipRanks’ Stock Analysis page.